|
|
||||||||
Raymond Escourolle Neuropathology Laboratory (Dr. Hauw), INSERM U 360, Hôpital de la Salpêtrière, Paris, France; the Parkinson's Disease Society Brain Tissue Bank and Department of Neuropathology (Dr. Daniel), Institute of Neurology, London, UK; the Department of Neuropathology (Dr. Dickson), Albert Einstein College of Medicine, Bronx, NY; the Department of Pathology (Neuropathology) (Dr. Horoupian), Stanford School of Medicine, San Francisco, CA; the Ludwig Boltzmann Institute of Clinical Neurobiology (Dr. Jellinger), Vienna, Austria; the Department of Neuropathology (Dr. Lantos), Institute of Psychiatry, London, UK; the Department of Neuropathology (Dr. McKee), Massachusetts General Hospital, Boston, MA; the Division of Neuropathology (Dr. Tabaton), Case Western Reserve University, Cleveland, OH; and the Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
We present the preliminary neuropathologic criteria for progressive supranuclear palsy (PSP) as proposed at a workshop held at the National Institutes of Health, Bethesda, MD, April 24 and 25, 1993. The criteria distinguish typical, atypical, and combined PSP. A semiquantitative distribution of neurofibrillary tangles is the basis for the diagnosis of PSP. A high density of neurofibrillary tangles and neuropil threads in the basal ganglia and brainstem is crucial for the diagnosis of typical PSP. Tau-positive astrocytes or their processes in areas of involvement help to confirm the diagnosis. Atypical cases of PSP are variants in which the severity or distribution of abnormalities deviates from the typical pattern. Criteria excluding the diagnosis of typical and atypical PSP are large or numerous infarcts, marked diffuse or focal atrophy, Lewy bodies, changes diagnostic of Alzheimer's disease, oligodendroglial argyrophilic inclusions, Pick bodies, diffuse spongiosis, and prion protein-positive amyloid plaques. The diagnosis of combined PSP is proposed when other neurologic disorders exist concomitantly with PSP.
Address correspondence and reprint requests to Prof. J.-J. Hauw, Laboratoire de Neuropathologie Raymond Escourolle, Hôpital de la Salpêtrière, 47 Bd de l' Hôpital, 75651 Paris, Cedex 13, France, or Dr. Irene Litvan, Federal Building, Room 714, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
The workshop was funded by the National Institute of Neurological Disorders and Stroke. Dr. S.E. Daniel is supported by a grant from the Parkinson's Disease Society of the United Kingdom. Support from the Medical Research Council to Prof. P.L. Lantos is acknowledged.
Received April 26,1994. Accepted in final form May 23,1994
This article has been cited by other articles:
![]() |
A.M. Tokumaru, Y. Saito, S. Murayama, K. Kazutomi, Y. Sakiyama, M. Toyoda, M. Yamakawa, and H. Terada Imaging-Pathologic Correlation in Corticobasal Degeneration AJNR Am. J. Neuroradiol., November 1, 2009; 30(10): 1884 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, R. J. Ivnik, P. Vemuri, J. L. Gunter, M. L. Senjem, M. M. Shiung, B. F. Boeve, D. S. Knopman, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study Brain, November 1, 2009; 132(11): 2932 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
B C P Ghosh, J B Rowe, A J Calder, J R Hodges, and T H Bak Emotion recognition in progressive supranuclear palsy J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1143 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, J. E. Ahlskog, J. E. Parisi, B. F. Boeve, B. A. Crum, C. Giannini, and R. C. Petersen Rapidly Progressive Neurodegenerative Dementias Arch Neurol, February 1, 2009; 66(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chastan, G. W. M. Westby, J. Yelnik, E. Bardinet, M. C. Do, Y. Agid, and M. L. Welter Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease Brain, January 1, 2009; 132(1): 172 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bensimon, A. Ludolph, Y. Agid, M. Vidailhet, C. Payan, P. N. Leigh, and for the NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study Brain, January 1, 2009; 132(1): 156 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zampieri and R. P Di Fabio Balance and Eye Movement Training to Improve Gait in People With Progressive Supranuclear Palsy: Quasi-Randomized Clinical Trial Physical Therapy, December 1, 2008; 88(12): 1460 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rizzo, P. Martinelli, D. Manners, C. Scaglione, C. Tonon, P. Cortelli, E. Malucelli, S. Capellari, C. Testa, P. Parchi, et al. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease Brain, October 1, 2008; 131(10): 2690 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees Clinical outcomes of progressive supranuclear palsy and multiple system atrophy Brain, May 1, 2008; 131(5): 1362 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ahmed, K. A. Josephs, J. Gonzalez, A. DelleDonne, and D. W. Dickson Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy Brain, February 1, 2008; 131(2): 460 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Grossman, E. M. Wood, P. Moore, M. Neumann, L. Kwong, M. S. Forman, C. M. Clark, L. F. McCluskey, B. L. Miller, V. M.-Y. Lee, et al. TDP-43 Pathologic Lesions and Clinical Phenotype in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions Arch Neurol, October 1, 2007; 64(10): 1449 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Kaat, A.J.W. Boon, W. Kamphorst, R. Ravid, H. J. Duivenvoorden, and J. C. van Swieten Frontal presentation in progressive supranuclear palsy Neurology, August 21, 2007; 69(8): 723 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Van Deerlin, E. M. Wood, P. Moore, W. Yuan, M. S. Forman, C. M. Clark, M. Neumann, L. K. Kwong, J. Q. Trojanowski, V. M.-Y. Lee, et al. Clinical, Genetic, and Pathologic Characteristics of Patients With Frontotemporal Dementia and Progranulin Mutations Arch Neurol, August 1, 2007; 64(8): 1148 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Golbe, B. F. Boeve, B. M. Keegan, and J. E. Parisi An 81-year-old man with imbalance and memory impairment Neurology, April 3, 2007; 68(14): 1147 - 1152. [Full Text] [PDF] |
||||
![]() |
J. L. Whitwell, C. R. Jack Jr, J. E. Parisi, D. S. Knopman, B. F. Boeve, R. C. Petersen, T. J. Ferman, D. W. Dickson, and K. A. Josephs Rates of cerebral atrophy differ in different degenerative pathologies Brain, April 1, 2007; 130(4): 1148 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Bloch, J L Houeto, S Tezenas du Montcel, F Bonneville, F Etchepare, M L Welter, S Rivaud-Pechoux, V Hahn-Barma, T Maisonobe, C Behar, et al. Parkinson's disease with camptocormia J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1223 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nicoletti, R. Lodi, F. Condino, C. Tonon, F. Fera, E. Malucelli, D. Manners, M. Zappia, L. Morgante, P. Barone, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy Brain, October 1, 2006; 129(10): 2679 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Levy and B. Dubois Apathy and the Functional Anatomy of the Prefrontal Cortex-Basal Ganglia Circuits Cereb Cortex, July 1, 2006; 16(7): 916 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, J. R. Duffy, E. A. Strand, J. L. Whitwell, K. F. Layton, J. E. Parisi, M. F. Hauser, R. J. Witte, B. F. Boeve, D. S. Knopman, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech Brain, June 1, 2006; 129(6): 1385 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, R. C. Petersen, D. S. Knopman, B. F. Boeve, J. L. Whitwell, J. R. Duffy, J. E. Parisi, and D. W. Dickson Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP Neurology, January 10, 2006; 66(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Halliday, V. Macdonald, and J. M. Henderson A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease Brain, October 1, 2005; 128(10): 2272 - 2280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Johnson, J. Diehl, M. F. Mendez, J. Neuhaus, J. S. Shapira, M. Forman, D. J. Chute, E. D. Roberson, C. Pace-Savitsky, M. Neumann, et al. Frontotemporal Lobar Degeneration: Demographic Characteristics of 353 Patients Arch Neurol, June 1, 2005; 62(6): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Cordato, A. J. Duggins, G. M. Halliday, J. G. L. Morris, and C. Pantelis Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy Brain, June 1, 2005; 128(6): 1259 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Paviour, S. L. Price, J. M. Stevens, A. J. Lees, and N. C. Fox Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy Neurology, February 22, 2005; 64(4): 675 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papapetropoulos, T. Scaravilli, H. Morris, S. F. An, D. C. Henderson, N. P. Quinn, F. Scaravilli, and K. P. Bhatia Young onset limb spasticity with PSP-like brain and spinal cord NFT-tau pathology Neurology, February 22, 2005; 64(4): 731 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Soliveri, S. Piacentini, and F. Girotti Limb apraxia in corticobasal degeneration and progressive supranuclear palsy Neurology, February 8, 2005; 64(3): 448 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
D C Paviour, J M Schott, J M Stevens, T Revesz, J L Holton, M N Rossor, A J Lees, and N C Fox Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1772 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Paviour, A. J. Lees, K. A. Josephs, T. Ozawa, M. Ganguly, C. Strand, A. Godbolt, R. S. Howard, T. Revesz, and J. L. Holton Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy Brain, November 1, 2004; 127(11): 2441 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rub, K. Burk, L. Schols, E. R. Brunt, R. A.I. de Vos, G. O. Diaz, K. Gierga, E. Ghebremedhin, C. Schultz, D. Del Turco, et al. Damage to the reticulotegmental nucleus of the pons in spinocerebellar ataxia type 1, 2, and 3 Neurology, October 12, 2004; 63(7): 1258 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, Y. Tsuboi, N. Cookson, H. Watt, and D. W. Dickson Apolipoprotein E {varepsilon}4 Is a Determinant for Alzheimer-Type Pathologic Features in Tauopathies, Synucleinopathies, and Frontotemporal Degeneration Arch Neurol, October 1, 2004; 61(10): 1579 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Brenneis, K Seppi, M Schocke, T Benke, G K Wenning, and W Poewe Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 246 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Soliveri, G. Rossi, D. Monza, F. Tagliavini, S. Piacentini, A. Albanese, O. Bugiani, and F. Girotti A Case of Dementia Parkinsonism Resembling Progressive Supranuclear Palsy Due to Mutation in the Tau Protein Gene Arch Neurol, October 1, 2003; 60(10): 1454 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuboi, J. Slowinski, K. A. Josephs, W. G. Honer, Z. K. Wszolek, and D. W. Dickson Atrophy of superior cerebellar peduncle in progressive supranuclear palsy Neurology, June 10, 2003; 60(11): 1766 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Nath, Y. Ben-Shlomo, R.G. Thomson, A.J. Lees, and D.J. Burn Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study Neurology, March 25, 2003; 60(6): 910 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Goetz, S. Leurgans, A. E. Lang, and I. Litvan Progression of gait, speech and swallowing deficits in progressive supranuclear palsy Neurology, March 25, 2003; 60(6): 917 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuboi, K. A. Josephs, N. Cookson, and D. W. Dickson APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy Neurology, January 28, 2003; 60(2): 240 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Fitzmaurice, C. L. Bamsey, L. Ang, M. Guttman, A. H. Rajput, Y. Furukawa, and S. J. Kish Brain aconitase activity is not decreased in progressive supranuclear palsy Neurology, July 9, 2002; 59(1): 137 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Morris, G. Gibb, R. Katzenschlager, N. W. Wood, D. P. Hanger, C. Strand, T. Lashley, S. E. Daniel, A. J. Lees, B. H. Anderton, et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy Brain, May 1, 2002; 125(5): 969 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, T. J. Desmond, R. L. Albin, and K. A. Frey Cholinergic vesicular transporters in progressive supranuclear palsy Neurology, April 9, 2002; 58(7): 1013 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hughes, S. E. Daniel, Y. Ben-Shlomo, and A. J. Lees The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain, April 1, 2002; 125(4): 861 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
H R Morris, R Katzenschlager, J C Janssen, J M Brown, M Ozansoy, N Quinn, T Revesz, M N Rossor, S E Daniel, N W Wood, et al. Sequence analysis of tau in familial and sporadic progressive supranuclear palsy J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 388 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Tawana and D B Ramsden Progressive supranuclear palsy Mol. Pathol., December 1, 2001; 54(6): 427 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. McKhann, M. S. Albert, M. Grossman, B. Miller, D. Dickson, and J. Q. Trojanowski Clinical and Pathological Diagnosis of Frontotemporal Dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol, November 1, 2001; 58(11): 1803 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hughes, S. E. Daniel, and A. J. Lees Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease Neurology, October 23, 2001; 57(8): 1497 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. K. Wszolek, Y. Tsuboi, R. J. Uitti, L. Reed, M. L. Hutton, D. W. Dickson, P. M. Stanford, G. M. Halliday, W. S. Brooks, J. B.J. Kwok, et al. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation Brain, August 1, 2001; 124(8): 1666 - 1670. [Full Text] [PDF] |
||||
![]() |
U. Nath, Y. Ben-Shlomo, R. G. Thomson, H. R. Morris, N. W. Wood, A. J. Lees, and D. J. Burn The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK Brain, July 1, 2001; 124(7): 1438 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Kluin, S. Gilman, N. L. Foster, A. A. F. Sima, C. J. D'Amato, L. A. Bruch, L. Bluemlein, R. Little, and J. Johanns Neuropathological Correlates of Dysarthria in Progressive Supranuclear Palsy Arch Neurol, February 1, 2001; 58(2): 265 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ondo, D. Warrior, A. Overby, J. Calmes, N. Hendersen, S. Olson, and J. Jankovic Computerized Posturography Analysis of Progressive Supranuclear Palsy: A Case-Control Comparison With Parkinson's Disease and Healthy Controls Arch Neurol, October 1, 2000; 57(10): 1464 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gwinn-Hardy, J. Y. Chen, H.-C. Liu, T. Y. Liu, M. Boss, W. Seltzer, A. Adam, A. Singleton, W. Koroshetz, C. Waters, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese Neurology, September 26, 2000; 55(6): 800 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Henderson, K. Carpenter, H. Cartwright, and G. M. Halliday Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications Brain, July 1, 2000; 123(7): 1410 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kimber, C. J. Mathias, A. J. Lees, K. Bleasdale-Barr, H. S. Chang, A. Churchyard, and L. Watson Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy Brain, July 1, 2000; 123(7): 1422 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
H U Rehman Progressive supranuclear palsy Postgrad. Med. J., June 1, 2000; 76(896): 333 - 336. [Abstract] [Full Text] |
||||
![]() |
G. M. Halliday, C. D. Hardman, N. J. Cordato, M. A. Hely, and J. G. L. Morris A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy Brain, April 1, 2000; 123(4): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P S Mathuranath, J. H Xuereb, T. Bak, and J. R Hodges Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 304 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Kuo, T. A. Kokjohn, M. D. Watson, A. S. Woods, R. J. Cotter, L. I. Sue, W. M. Kalback, M. R. Emmerling, T. G. Beach, and A. E. Roher Elevated A{beta}42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of A{beta}PP Metabolism Am. J. Pathol., March 1, 2000; 156(3): 797 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hoenicka, M. Perez, J. Perez-Tur, A. Barabash, M. Godoy, L. Vidal, R. Astarloa, J. Avila, T. Nygaard, and J. G. de Yebenes The tau gene A0 allele and progressive supranuclear palsy Neurology, October 1, 1999; 53(6): 1219 - 1219. [Abstract] [Full Text] |
||||
![]() |
H. R Morris, N. W Wood, and A. J Lees Classic diseases revisited: Progressive supranuclear palsy (Steele-Richardson-Olszewski disease) Postgrad. Med. J., October 1, 1999; 75(888): 579 - 584. [Abstract] [Full Text] |
||||
![]() |
A. Rojo, R. S. Pernaute, A. Fontan, P. G. Ruiz, J. Honnorat, T. Lynch, S. Chin, I. Gonzalo, A. Rabano, A. Martinez, et al. Clinical genetics of familial progressive supranuclear palsy Brain, July 1, 1999; 122(7): 1233 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
H R Morris, J C Janssen, O Bandmann, S E Daniel, M N Rossor, A J Lees, and N W Wood The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases J. Neurol. Neurosurg. Psychiatry, May 1, 1999; 66(5): 665 - 667. [Abstract] [Full Text] |
||||
![]() |
D. J. Gelb, E. Oliver, and S. Gilman Diagnostic Criteria for Parkinson Disease Arch Neurol, January 1, 1999; 56(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Litvan, J. S. Paulsen, M. S. Mega, and J. L. Cummings Neuropsychiatric Assessment of Patients With Hyperkinetic and Hypokinetic Movement Disorders Arch Neurol, October 1, 1998; 55(10): 1313 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kompoliti, C. G. Goetz, I. Litvan, K. Jellinger, and M. Verny Pharmacological Therapy in Progressive Supranuclear Palsy Arch Neurol, August 1, 1998; 55(8): 1099 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Oliva, E. Tolosa, M. Ezquerra, J. L. Molinuevo, F. Valldeoriola, J. Burguera, M. Calopa, M. Villa, and F. Ballesta Significant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver Detection Arch Neurol, August 1, 1998; 55(8): 1122 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Litvan, A. MacIntyre, C. G. Goetz, G. K. Wenning, K. Jellinger, M. Verny, J. J. Bartko, J. Jankovic, A. McKee, J. P. Brandel, et al. Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies: A Clinicopathologic Study Arch Neurol, July 1, 1998; 55(7): 969 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Litvan and A. M. Saunders Apolipoprotein E{epsilon}4 (Epsilon) Allele Does Not Affect the Onset or Symptom Severity in Progressive Supranuclear Palsy Arch Neurol, May 1, 1998; 55(5): 752 - 754. [Full Text] [PDF] |
||||
![]() |
G K Wenning, I Litvan, J Jankovic, R Granata, C A Mangone, A McKee, W Poewe, K Jellinger, K R. Chaudhuri, L D'Olhaberriague, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 184 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ghika and J. Bogousslavsky Presymptomatic Hypertension Is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy Arch Neurol, September 1, 1997; 54(9): 1104 - 1108. [Abstract] [PDF] |
||||
![]() |
I. Litvan, C. G. Goetz, J. Jankovic, G. K. Wenning, V. Booth, J. J. Bartko, A. McKee, K. Jellinger, E. C. Lai, J.-P. Brandel, et al. What Is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy? A Clinicopathologic Study Arch Neurol, August 1, 1997; 54(8): 937 - 944. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |